Skyepharma Competitors and Similar CompaniesClear all

Skyepharma's competitors and similar companies include Array BioPharma and Amicus Therapeutics.
Skyepharma
Skyepharma
Skyepharma is a drug delivery company developing oral and inhalation products.
Array BioPharma
Array BioPharma
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Founding Date
Founding Date
1996
Founding Date
1998
Founding Date
2002
Type
Type
Subsidiary
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Saint-Quentin-Fallavier, FR HQ
Locations
Boulder, US HQ
Chicago, US
Detroit, US
Houston, US
Miami, US
New York, US
Phoenix, US
Locations
Philadelphia, US HQ
Northbridge, AU
Pointe Claire, CA
Paris, FR
München, DE
Dublin, IE
Milano, IT
see more
Employees
Employees
2061% increase
Employees
29843% increase
Employees
58415% increase

Financial

Revenue (est.)
Revenue (est.)
£95.9m (FY, 2015)
Revenue (est.)
$173.8m (FY, 2018)
Revenue (est.)
$399.4m (FY, 2023)
Cost of goods
Cost of goods
£43.1m (FY, 2015)
Cost of goods
$59.4m (FY, 2018)
Cost of goods
$37.3m (FY, 2023)
Gross profit
Gross profit
£52.8m (FY, 2015)
Gross profit
$114.4m (FY, 2018)
Gross profit
$362m (FY, 2023)
Net income
Net income
N/A
Net income
($147.7m) (FY, 2018)
Net income
($151.6m) (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

Array BioPharma
HQ
Boulder, US

Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

View company
Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company